Patient-reported outcome measures in urology

Current Opinion in Urology
Gopal L NarangJonathan Bergman

Abstract

Many urologic treatments have similar clinical outcomes, necessitating alternative methods to discriminate between options. Patient-reported outcome measures (PROMs) have become the new standard for evaluating the patient experience, and their use has drastically increased over the past decade. The purpose of this review is to discuss the status of PROMs in urology, highlight commonly used tools and address their future direction. An increasing number of urology-specific PROMs tools have been developed and validated. An increased focus on patient-centered care has provided an impetus for their rise in use. Implementation of PROMs has transitioned from being primarily descriptive in nature to producing actionable findings. Many PROMs are now implemented in daily clinical practice. The future of PROMs will involve new instrument development, integration into clinical practice and the use of PROMs as performance measures. PROMs are effective tools for characterizing symptom burden and health-related quality of life. With increasing clinical implementation, PROMs are playing an increasing role in patients' clinical decision-making.

References

Mar 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F CellaJ Brannon
Jun 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I F TannockK C Murphy
Apr 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·G Borghede, M Sullivan
Feb 3, 2000·Journal of the National Cancer Institute·S J LeeJ C Weeks
Aug 2, 2002·International Journal of Impotence Research·R C RosenN Gendrano
Oct 1, 2003·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M F BottemanA Redaelli
Sep 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Erik K FrommeTomasz M Beer
May 6, 2005·International Journal of Impotence Research·J C Cappelleri, R C Rosen
Jan 19, 2006·Advances in Therapy·Karin S CoyneRichard G Roberts
Mar 10, 2007·Nature Clinical Practice. Urology·Jonathan L Wright, Michael P Porter
Jun 16, 2007·Health and Quality of Life Outcomes·Gale HardingDennis A Revicki
Jul 25, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·David CellaWilliam P Bro
Jan 22, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·David H HenryDavid Cella
Mar 4, 2008·Cancer Treatment Reviews·Kiran GuptaClaudie Charbonneau
Mar 21, 2008·The New England Journal of Medicine·Martin G SandaJohn T Wei
Mar 28, 2008·International Journal of Impotence Research·J C Cappelleri, V J Stecher
Sep 9, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·George van AndelNeil K Aaronson
Sep 23, 2010·Health and Quality of Life Outcomes·Eivor A LaugsandPål Klepstad
Oct 11, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Thomas M AtkinsonEthan Basch
Apr 19, 2012·JAMA : the Journal of the American Medical Association·Joe V SelbyLori Frank
May 17, 2012·International Urogynecology Journal·Sheng-Mou HsiaoHann-Chorng Kuo
Jun 8, 2012·Neurourology and Urodynamics·Barbara A BrandtZoe S Kopp
Jul 31, 2012·European Urology·Steven MacLennanUNKNOWN EAU Renal Cancer Guideline Panel
Jan 15, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Carolyn Miller ReillyBryce B Reeve
Mar 21, 2013·The Journal of Sexual Medicine·Kathryn E FlynnKevin P Weinfurt
Mar 19, 2013·Health and Quality of Life Outcomes·Kathryn E FlynnKevin P Weinfurt
Jul 11, 2013·JAMA : the Journal of the American Medical Association·Ethan BaschKaren Adams
Aug 21, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Nan E RothrockDavid Cella
Oct 15, 2013·International Journal of Urology : Official Journal of the Japanese Urological Association·Hironobu AkinoOsamu Yokoyama
Dec 10, 2013·The Journal of Sexual Medicine·Emmanuele A JanniniChiara Simonelli

❮ Previous
Next ❯

Citations

May 4, 2018·The Journal of Urology·Jennifer L PortisAndrew J Portis
May 8, 2019·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Lisley Keller Liidtke CintraCristiano Mendes Gomes
Sep 27, 2019·Nature Reviews. Urology·Chad Ellimoottil
Jul 4, 2019·Journal of Medical Internet Research·Rob A A van KollenburgHessel Wijkstra
Feb 24, 2021·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Caroline Santos SilvaJosé de Bessa
Jul 1, 2021·Patient Preference and Adherence·Graham R HaleRyan W Dobbs

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.